Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages

Cytokine

Volumn 28, Issue 1, 2004, Pages 35-47

  Pertyńska Marczewska, Magdalena ^a,b   Kiriakidis, Serafim ^a   Wait, Robin ^a   Beech, Jonathan ^a   Feldmann, Marc ^a   Paleolog, Ewa M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Advanced glycation end products; Angiogenic and pro inflammatory cytokines; Microvascular complications

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; BOVINE SERUM ALBUMIN; CYTOKINE; GLUCOSE; GLYOXYLIC ACID; HUMAN SERUM ALBUMIN; INTERLEUKIN 8; LYSINE DERIVATIVE; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GLYCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STIMULATION; TECHNIQUE; TIME SERIES ANALYSIS; UPREGULATION;

CELL LINE; CYTOKINES; GENE EXPRESSION REGULATION; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION; MACROPHAGES; MONOCYTES; NEOVASCULARIZATION, PATHOLOGIC; SERUM ALBUMIN; SERUM ALBUMIN, BOVINE;

EID: 4444375274     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2004.06.006     Document Type: Article

References (55)

1. J.W. Baynes The role of AGEs in aging: causation or correlation Exp Gerontol 36 2001 1527 1537
2. H. Vlassara, and M.R. Palace Diabetes and advanced glycation endproducts J Intern Med 251 2002 87 101
3. R. Singh, A. Barden, T. Mori, and L. Beilin Advanced glycation end-products: a review Diabetologia 44 2001 129 146
4. K. Ikeda, T. Higashi, H. Sano, Y. Jinnouchi, M. Yoshida, and T. Araki N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction Biochemistry 35 1996 8075 8083
5. O. Chappey, C. Dosquet, M.P. Wautier, and J.L. Wautier Advanced glycation end products, oxidant stress and vascular lesions Eur J Clin Invest 27 1997 97 108
6. H. Vlassara Advanced glycation end-products and atherosclerosis Ann Med 28 1996 419 426
7. A.S. Krolewski, J.H. Warram, P. Valsania, B.C. Martin, L.M. Laffel, and A.R. Christlieb Evolving natural history of coronary artery disease in diabetes mellitus Am J Med 90 1991 56S 61S
8. Y. Nakamura, Y. Horii, T. Nishino, H. Shiiki, Y. Sakaguchi, and T. Kagoshima Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus Am J Pathol 143 1993 1649 1656
9. S. Kume, M. Takeya, T. Mori, N. Araki, H. Suzuki, and S. Horiuchi Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody Am J Pathol 147 1995 654 667
10. N. Sasaki, R. Fukatsu, K. Tsuzuki, Y. Hayashi, T. Yoshida, and N. Fujii Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases Am J Pathol 153 1998 1149 1155
11. K. Horie, T. Miyata, K. Maeda, S. Miyata, S. Sugiyama, and H. Sakai Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy J Clin Invest 100 1997 2995 3004
12. H. Vlassara Advanced glycation in diabetic renal and vascular disease Kidney Int Suppl 51 1995 S43 S44
13. R. Bucala, Z. Makita, G. Vega, S. Grundy, T. Koschinsky, and A. Cerami Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency Proc Natl Acad Sci U S A 91 1994 9441 9445
14. S. Ligier, P.R. Fortin, and M.M. Newkirk A new antibody in rheumatoid arthritis targeting glycated IgG: IgM anti-IgG-AGE Br J Rheumatol 37 1998 1307 1314
15. A.W. Tai, and M.M. Newkirk An autoantibody targeting glycated IgG is associated with elevated serum immune complexes in rheumatoid arthritis (RA) Clin Exp Immunol 120 2000 188 193
16. J. Rodriguez-Garcia, J.R. Requena, and S. Rodriguez-Segade Increased concentrations of serum pentosidine in rheumatoid arthritis Clin Chem 44 1998 250 255
17. M.M. Newkirk, R. Goldbach-Mansky, J. Lee, J. Hoxworth, A. McCoy, and C. Yarboro Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis Arthritis Res Ther 5 2003 R82 R90
18. T. Miyata, N. Ishiguro, Y. Yasuda, T. Ito, M. Nangaku, and H. Iwata Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers Biochem Biophys Res Commun 244 1998 45 49
19. J.R. Chen, M. Takahashi, M. Suzuki, K. Kushida, S. Miyamoto, and T. Inoue Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis J Rheumatol 25 1998 2440 2444
20. A. Bierhaus, T. Illmer, M. Kasper, T. Luther, P. Quehenberger, and H. Tritschler Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE Circulation 96 1997 2262 2271
21. C. Min, E. Kang, S.H. Yu, S.H. Shinn, and Y.S. Kim Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells Diabetes Res Clin Pract 46 1999 197 202
22. S. Yamagishi, H. Fujimori, H. Yonekura, Y. Yamamoto, and H. Yamamoto Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells Diabetologia 41 1998 1435 1441
23. A.M. Schmidt, O. Hori, J.X. Chen, J.F. Li, J. Crandall, and J. Zhang Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes J Clin Invest 96 1995 1395 1403
24. G. Basta, G. Lazzerini, M. Massaro, T. Simoncini, P. Tanganelli, and C. Fu Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses Circulation 105 2002 816 822
25. Y. Iida, T. Miyata, R. Inagi, S. Sugiyama, and K. Maeda Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis Biochem Biophys Res Commun 201 1994 1235 1241
26. E.A. Abordo, and P.J. Thornalley Synthesis and secretion of tumour necrosis factor-alpha by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts Immunol Lett 58 1997 139 147
27. T. Miyata, R. Inagi, Y. Iida, M. Sato, N. Yamada, and O. Oda Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1 J Clin Invest 93 1994 521 528
28. T. Okamoto, S. Tanaka, A.C. Stan, T. Koike, M. Kase, and Z. Makita Advanced glycation end products induce angiogenesis in vivo Microvasc Res 63 2002 186 195
29. C. Hirata, K. Nakano, N. Nakamura, Y. Kitagawa, H. Shigeta, and G. Hasegawa Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells Biochem Biophys Res Commun 236 1997 712 715
30. M. Lu, M. Kuroki, S. Amano, M. Tolentino, K. Keough, and I. Kim Advanced glycation end products increase retinal vascular endothelial growth factor expression J Clin Invest 101 1998 1219 1224
31. C. Treins, S. Giorgetti-Peraldi, J. Murdaca, and E. Van Obberghen Regulation of vascular endothelial growth factor expression by advanced glycation end products J Biol Chem 276 2001 43836 43841
32. S. Yamagishi, S. Amano, Y. Inagaki, T. Okamoto, K. Koga, and N. Sasaki Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes Biochem Biophys Res Commun 290 2002 973 978
33. Y. Urata, M. Yamaguchi, Y. Higashiyama, Y. Ihara, S. Goto, and M. Kuwano Reactive oxygen species accelerate production of vascular endothelial growth factor by advanced glycation end products in RAW264.7 mouse macrophages Free Radic Biol Med 32 2002 688 701
34. H.J. Huttunen, C. Fages, and H. Rauvala Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways J Biol Chem 274 1999 19919 19924
35. S.M. Twigg, M.M. Chen, A.H. Joly, S.D. Chakrapani, J. Tsubaki, and H.S. Kim Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential mechanism for expansion of extracellular matrix in diabetes mellitus Endocrinology 142 2001 1760 1769
36. G. Pugliese, F. Pricci, G. Leto, L. Amadio, C. Iacobini, and G. Romeo The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression Diabetes 49 2000 1249 1257
37. M.E. Westwood, O.K. Argirov, E.A. Abordo, and P.J. Thornalley Methylglyoxal-modified arginine residues - a signal for receptor-mediated endocytosis and degradation of proteins by monocytic THP-1 cells Biochim Biophys Acta 1356 1997 84 94
38. T. Kislinger, C. Fu, B. Huber, W. Qu, A. Taguchi, and S. Du Yan N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression J Biol Chem 274 1999 31740 31749
39. P. Jeno, T. Mini, S. Moes, E. Hintermann, and M. Horst Internal sequences from proteins digested in polyacrylamide gels Anal Biochem 224 1995 75 82
40. M. Wilm, A. Shevchenko, T. Houthaeve, S. Breit, L. Schweigerer, and T. Fotsis Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry Nature 379 1996 466 469
41. R. Wait, E. Gianazza, I. Eberini, L. Sironi, M.J. Dunn, and M. Gemeiner Proteins of rat serum, urine, and cerebrospinal fluid: VI. Further protein identifications and interstrain comparison Electrophoresis 22 2001 3043 3052
42. R. Wait, I. Miller, I. Eberini, F. Cairoli, C. Veronesi, and M. Battocchio Strategies for proteomics with incompletely characterized genomes: the proteome of Bos taurus serum Electrophoresis 23 2002 3418 3427
43. B. Foxwell, K. Browne, J. Bondeson, C. Clarke, R. de Martin, and F. Brennan Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent Proc Natl Acad Sci U S A 95 1998 8211 8215
44. S. Kiriakidis, E. Andreakos, C. Monaco, B. Foxwell, M. Feldmann, and E. Paleolog VEGF expression in human macrophages is NF-κB-dependent: studies using adenoviruses expressing the endogenous NF-κB inhibitor IκBα and a kinase defective form of the IκB kinase 2 J Cell Sci 116 2003 665 674
45. A.W. Stitt, A.J. Jenkins, and M.E. Cooper Advanced glycation end products and diabetic complications Expert Opin Investig Drugs 11 2002 1205 1223
46. J.W. Baynes, and S.R. Thorpe Glycoxidation and lipoxidation in atherogenesis Free Radic Biol Med 28 2000 1708 1716
47. T. Murata, R. Nagai, T. Ishibashi, H. Inomuta, K. Ikeda, and S. Horiuchi The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas Diabetologia 40 1997 764 769
48. E.M. Paleolog, S. Young, A.C. Stark, R.V. McCloskey, M. Feldmann, and R.N. Maini Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis Arthritis Rheum 41 1998 1258 1265
49. G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak Vascular endothelial growth factor (VEGF) and its receptors FASEB J 13 1999 9 22
50. G.E. Salvi, J.G. Collins, B. Yalda, R.R. Arnold, N.P. Lang, and S. Offenbacher Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases J Clin Periodontol 24 1997 8 16
51. K. Ichikawa, M. Yoshinari, M. Iwase, M. Wakisaka, Y. Doi, and K. Iino Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients Atherosclerosis 136 1998 281 287
52. H. Vlassara, L. Moldawer, and B. Chan Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor J Clin Invest 84 1989 1813 1820
53. M. Clauss, M. Grell, C. Fangmann, W. Fiers, P. Scheurich, and W. Risau Synergistic induction of endothelial tissue factor by tumor necrosis factor and vascular endothelial growth factor: functional analysis of the tumor necrosis factor receptors FEBS Lett 390 1996 334 338
54. A.W. Stitt, C. He, and H. Vlassara Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells Biochem Biophys Res Commun 256 1999 549 556
55. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J Clin Invest 108 2001 949 955